FDA-Drug2026-06-24Class IICHEMICAL
Inventia Healthcare chlorthalidone 25 mg tablets recalled for failed dissolution
What this means
Inventia Healthcare Limited's chlorthalidone 25 mg tablets failed to meet dissolution specifications, meaning the tablets may not break down properly in the body and deliver the full dose. This affects 100-tablet and 1000-tablet bottles distributed nationwide. No injuries have been reported.
- Check if you have chlorthalidone 25 mg tablets from Inventia Healthcare (NDC 64980-599-01 or 64980-599-10) with batch RISA24001 or RISB24002.
- Contact your pharmacist or doctor before stopping this blood pressure medication.
- Do not stop taking your chlorthalidone without medical guidance, as suddenly stopping can raise blood pressure.
- Return the recalled tablets to your pharmacy.
The agency's original wording
Hazard
Failed Dissolution Specifications
Intended for
Adults
Illnesses reported
None reported
Sold states
U.S. Nationwide.
Affected count
11,460 bottles
Manufactured in
Additional Ambernath Midc, Ambernath East; F1-F1/1-F75/1, Kalyan, India
Products
Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0610-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.